Trade LIMN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Liminatus Pharma, Inc. Class A (LIMN) is trading at US$3.71, up 0.27% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$6.93M. Over the past 52 weeks, LIMN has traded between US$3.42 and US$141.50. On Syfe you can trade LIMN with $0 commission and add it to your watchlist.
| Previous close | US$3.70 |
|---|---|
| Market cap | US$6.93M |
| 52-week range | US$3.42 – US$141.50 |
| Volume | 23.2K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Liminatus Pharma, Inc. Class A
Liminatus Pharma, Inc. is a pre-clinical stage biopharmaceutical company, which engages in developing novel, immune-modulating cancer therapies. The company was founded on November 1, 2020 and is headquartered in Cerritos, CA.
Year: 2025
Top Premarket Gainers
Jul 2, 11:09 AM · MT Newswires
Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday
Jul 1, 1:20 PM · MT Newswires
Liminatus Pharma Amends Merger Deal With InnocsAI
Jul 1, 11:25 AM · MT Newswires
Top Premarket Decliners
May 22, 11:42 AM · MT Newswires
Liminatus Pharma, Inc. Class A (LIMN) stock is trading at US$3.71, +0.27% from the previous close of US$3.70.
The market cap for Liminatus Pharma, Inc. Class A (LIMN) stock is approximately US$6.93M.
The 52-week high for Liminatus Pharma, Inc. Class A (LIMN) stock is US$141.50.
The 52-week low for Liminatus Pharma, Inc. Class A (LIMN) stock is US$3.42.
Liminatus Pharma, Inc. Class A (LIMN) does not currently pay a dividend.
Stay on top of LIMN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
